PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+29.47%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.12B
AUM Growth
+$1.12B
(+22%)
Cap. Flow
+$76.8M
Cap. Flow
% of AUM
6.87%
Top 10 Holdings %
Top 10 Hldgs %
44.03%
Holding
175
New
50
Increased
49
Reduced
22
Closed
29
Top Buys
| 1 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$24.1M |
| 2 |
BLUE
bluebird bio
BLUE
|
$20.6M |
| 3 |
ANI Pharmaceuticals
ANIP
|
$17.6M |
| 4 |
Amicus Therapeutics
FOLD
|
$17.5M |
| 5 |
RLYP
RELYPSA INC COM
RLYP
|
$14.7M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$25.8M |
| 2 |
Neurocrine Biosciences
NBIX
|
$22.3M |
| 3 |
Arrowhead Research
ARWR
|
$18.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$15.5M |
| 5 |
DYAX
DYAX CORPORATION
DYAX
|
$13.8M |
Sector Composition
| 1 | Healthcare | 84.54% |
| 2 | Financials | 0.1% |
| 3 | Energy | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ardelyx
ARDX
$1.57B
| $4.83M | 0.41% |
255,728
+102,651
| +67% | +$1.94M |
|
52
Xenon Pharmaceuticals
XENE
$2.99B
| $4.44M | 0.37% |
+225,000
| New | +$4.44M |
|
53
Abeona Therapeutics
ABEO
$356M
| $4.38M | 0.37% |
+1,250,000
| New | +$4.38M |
|
54
Viatris
VTRS
$12.3B
| $4.3M | 0.36% |
76,210
+26,210
| +52% | +$1.48M |
|
|
FPRX
55
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.19M | 0.35% |
155,256
+5,256
| +4% | +$142K |
|
56
QuidelOrtho
QDEL
$1.87B
| $4.12M | 0.35% |
+142,500
| New | +$4.12M |
|
|
TTPH
57
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.97M | 0.33% |
+100,000
| New | +$3.97M |
|
|
AGN
58
DELISTED
Allergan plc
AGN
| $3.88M | 0.33% |
15,088
+88
| +0.6% | +$22.7K |
|
59
Tenet Healthcare
THC
$16.5B
| $3.85M | 0.32% |
75,913
+8,413
| +12% | +$426K |
|
|
ALR
60
DELISTED
Alere Inc
ALR
| $3.72M | 0.31% |
+98,000
| New | +$3.72M |
|
|
AVDL
61
Avadel Pharmaceuticals
AVDL
$1.42B
| $3.68M | 0.31% |
644,111
+34,111
| +6% | +$195K |
|
62
HCA Healthcare
HCA
$95.4B
| $3.57M | 0.3% |
48,639
-181,667
| -79% | -$13.3M |
|
|
ELGX
63
DELISTED
Endologix Inc
ELGX
| $3.21M | 0.27% |
+210,000
| New | +$3.21M |
|
|
DBVT
64
DBV Technologies
DBVT
$249M
| $3.05M | 0.26% |
+112,622
| New | +$3.05M |
|
|
PFNX
65
DELISTED
Pfenex Inc.
PFNX
| $2.96M | 0.25% |
404,665
+4,665
| +1% | +$34.1K |
|
|
VBLX
66
DELISTED
VASCULAR BIOGENICS LTD ORD SHS (ISR)
VBLX
| $2.96M | 0.25% |
+500,000
| New | +$2.96M |
|
|
DSCI
67
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $2.92M | 0.24% |
313,583
+97,774
| +45% | +$910K |
|
68
uniQure
QURE
$954M
| $2.9M | 0.24% |
+195,856
| New | +$2.9M |
|
69
Protara Therapeutics
TARA
$125M
| $2.86M | 0.24% |
+275,000
| New | +$2.86M |
|
|
DERM
70
DELISTED
Dermira, Inc.
DERM
| $2.75M | 0.23% |
+152,000
| New | +$2.75M |
|
|
JUNO
71
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.61M | 0.22% |
+50,000
| New | +$2.61M |
|
|
GNMX
72
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $2.6M | 0.22% |
514,224
+459,151
| +834% | +$2.32M |
|
73
Vericel Corp
VCEL
$1.69B
| $2.58M | 0.22% |
850,000
-250,000
| -23% | -$760K |
|
|
SAGE
74
DELISTED
Sage Therapeutics
SAGE
| $2.58M | 0.22% |
70,484
-138,192
| -66% | -$5.06M |
|
75
Smith & Nephew
SNN
$16.2B
| $2.48M | 0.21% |
67,407
+54,444
| +420% | +$1.29M |
|